Intrauterine fetal blood transfusion for treatment of fetal anemia in rh isoimmunized pregnancies and its outcome in neonates / Fatma Elzharaa Ahmed Mahmoud Mohamed ; Supervised Hala Mufeed Said , Ahmed Zakaria Elsheikhah , Sherif Elanwary Abdelmaneam
Material type:
- نقل الدم للجنين داخل الرحم لعلاج فقر الدم التكسيري للجنين في حالات الحمل المصحوبة بتكوين الأم لأجسام مناعية ضد عامل ريسيس لدي الجنين ونتائجه في حديثي الولادة [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2019.Fa.I (Browse shelf(Opens below)) | Not for loan | 01010110079063000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2019.Fa.I (Browse shelf(Opens below)) | 79063.CD | Not for loan | 01020110079063000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics
Background: Hemolytic disease of the fetus and newborn (HDFN) has been known as major problem in fetal and neonatal period. In-utero transfusion is now well under control and improves the survival of fetuses monitored for fetal anemia. Limited studies are available on the effect of IUT on postnatal outcome. Objectives: to assess the short-term neonatal outcome associated with prenatal therapy of Rh-alloimmunization (HDFN) by Doppler assessment of middle cerebral artery peak systolic velocity of blood flow for monitoring of fetal anemia (MCA-PSV) and management by Intrauterine Fetal Blood Transfusion (IUT) with chief concern to neurological impairment in neonates. Patients and Methods: cohort, observational study. The study was conducted at NICU wards of Cairo University and fetal medicine unit at Kasr El Aini maternity hospital, Cairo University. Neonates, suffered Rh-alloimmunization hemolytic disease, during the period from December 2015 through 2019, and met inclusion criteria, have been evaluated and categorized according to time of presentation in to prenatal group and postnatal group. However the prenatal group was monitored since their presentation during fetal period and was managed by IUT when needed. The neonatal outcome between the two study groups was compared
Issued also as CD
There are no comments on this title.